Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
In keeping with the programmatic theme of developmental toxicity, the goal of these studies is to determine
the molecular mechanisms by which environmental chemicals impair the development of the mammalian immune
system. Our previous studies demonstrated that environmentally ubiquitous aryl hydrocarbon receptor (AhR)
agonists profoundly affect immune system development by inducing bone marrow pro- and pro/pre-B lymphocyte
death. In the course of defining the molecular mechanisms through which this immunotoxicity is manifest, we
found that other environmental chemicals included on the list of priority chemicals designated by the Agency for
Toxic Substances and Disease Registry, notably agonists of the peroxisome proliferator activated receptor/
(PPARy) such as di-(2-ethylhexyl) phthalate/ mono-(2-ethylhexyl) phthalate, deliver a potent death signal that
involves intracellular signaling pathways distinct from those activated by AhR ligands. Furthermore, an
endogenous bone marrow-derived PPARy agonist, 15-deoxy-Al2|I4-prostaglandin J2, or a naturally occurring
RXRa agonist, 9-cw-retinoic acid, enhances the inhibition of B cell proliferation. Our working model of PPARy
agonist-induced death, which is based on a considerable foundation of new information, proposes a pathway that
involves the activation of and interaction between caspases, kinase signaling cascades and NF-KB. Accordingly,
three specific aims are proposed: 1. Map PPARy agonist-induced caspase-dependent bone marrow B cell apoptosis
signaling pathways. 2. Map the kinase activation cascade in PPARy agonist-induced death and define its
relationship to caspase and NF-KB activation. 3. Define the molecular mechanisms of chemical synergy resulting
in developing B cell apoptosis. These studies not only will contribute to our understanding of the molecular effects
of PPARy agonists on developing B cells, but also will validate a platform that is easily applicable to the study of
other immunotoxic environmental chemicals, either individually or in complex mixtures, at the molecular level.
National Institute of Environmental Health Sciences
CFDA Code
DUNS Number
604483045
UEI
FBYMGMHW4X95
Project Start Date
Project End Date
19-September-2012
Budget Start Date
01-April-2009
Budget End Date
31-March-2013
Project Funding Information for 2009
Total Funding
$235,750
Direct Costs
$144,338
Indirect Costs
$91,412
Year
Funding IC
FY Total Cost by IC
2009
National Institute of Environmental Health Sciences
$235,750
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P42ES007381-15 0020
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P42ES007381-15 0020
Patents
No Patents information available for 5P42ES007381-15 0020
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P42ES007381-15 0020
Clinical Studies
No Clinical Studies information available for 5P42ES007381-15 0020
News and More
Related News Releases
No news release information available for 5P42ES007381-15 0020
History
No Historical information available for 5P42ES007381-15 0020
Similar Projects
No Similar Projects information available for 5P42ES007381-15 0020